The FDA Office of Women’s Health (OWH) funds scientific research, workshops, and trainings to provide a foundation for the development of sound policies and regulations to enhance women’s health. To date, OWH has provided approximately $30 million for women’s health research initiatives on topics ranging from cancer, HIV, and osteoporosis to dietary supplements, dioxins, and statistical approaches to gender analysis.
The results of OWH funded research have been published in over 170 articles in peer-reviewed journals.
OWH funded research has impacted regulatory decision-making including guidance documents, label changes, and standards development.
Animal models developed with OWH funds have been used to further research and regulatory projects.
OWH scientific workshops have brought together representatives from government, industry, and academia to address vital women’s health issues.
- Projects by Year
- Projects by Therapeutic Category
- Projects on Women and Heart Disease
- Projects on the Participation of Women in Clinical Trials
- Pregnancy Research Initiatives
- Projects by (DHHS) National Centers of Excellence in Women’s Health (COE)
- OWH Accomplishment Report
Publications and Presentations
Scientific Workshops and Meetings
- Sex, Gender and Medicine - Meeting with the Karolinska Institutet of Sweden - June 2012
- Dialogues on Diversifying Clinical Trials Conference - September 22-23, 2011
- 2011 Pregnancy and Prescription Medication Use Symposium
- 2010 OWH Science Day Keynote Lecture: “Gender and the Genome: A Complicated and Still Unfolding Tale”
- Sex Differences and the FDA Critical Path Initiative
- Gender Studies in Product Development: Scientific Issues and Approaches
Web-based Tools for Health Professionals
- The Science of Sex and Gender in Human Health (joint project with NIH Office of Research on Women’s Health)
- Does My Patient Understand? (joint project with the HRSA Patient Safety and Clinical Pharmacy Services Collaborative)
- Pregnancy Exposure Registries Web-Portal